ARCHIVES

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

This article is from The Cancer Letter archive.

Vol. 01 No. 01 | January 3, 1975

Download PDF Visit The Full Archive

Related Articles

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

Specter Remains Chairman Of Labor-HHS Subcommittee.

February 2, 2001

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997